ArticleFrontiers in medicine2025
Skin-lesion segmentation using boundary-aware segmentation network and classification based on a mixture of convolutional and transformer neural networks.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Demographic Reporting and the Absence of Hispanic/Latino Representation in Dermatology Artificial Intelligence: A Scoping Review.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2026Article
- TriDermCancerNet: A hybrid deep learning framework for skin cancer classification.The Journal of international medical research · 2026Article
- Integrating features of radiomics and CNN models for early skin cancer detection based on watershed segmentation.Discover oncology · 2026Article
- HyperFusionNet combines vision transformer for early melanoma detection and precise lesion segmentation.Scientific reports · 2025Article
- Multi-interactive feature embedding learning for medical image segmentation.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Skin cancer is one of the most prevalent cancers worldwide. In the clinical domain, skin lesions such as melanoma detection are still a challenge due to occlusions, poor contrast, poor image quality, and similarities between skin lesions. Deep-/machine-learning methods are used for the early, accurate, and efficient detection of skin lesions. Therefore, we propose a boundary-aware segmentation network (BASNet) model comprising prediction and residual refinement modules. Materials and methods: The prediction module works like a U-Net and is densely supervised by an encoder and decoder. A hybrid loss function is used, which has the potential to help in the clinical domain of dermatology. BASNet handles these challenges by providing robust outcomes, even in suboptimal imaging environments. This leads to accurate early diagnosis, improved treatment outcomes, and efficient clinical workflows. We further propose a compact convolutional transformer model (CCTM) based on convolution and transformers for classification. This was designed on a selected number of layers and hyperparameters having two convolutions, two transformers, 64 projection dimensions, tokenizer, position embedding, sequence pooling, MLP, 64 batch size, two heads, 0.1 stochastic depth, 0.001 learning rate, 0.0001 weight decay, and 100 epochs. Results: The CCTM model was evaluated on six skin-lesion datasets, namely MED-NODE, PH2, ISIC-2019, ISIC-2020, HAM10000, and DermNet datasets, achieving over 98% accuracy. Conclusion: The proposed model holds significant potential in the clinical domain. Its ability to combine local feature extraction and global context understanding makes it ideal for tasks like medical image analysis and disease diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.